A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, Single-Dose Escalation Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04308515 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2010
At a glance
- Drugs PF 4308515 (Primary)
- Indications Inflammation
- Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2010 New trial record
- 03 Dec 2009 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov.